Arnicare Product Line Expands With New Homeopathic Arthritis Cream
Arnicare Arthritis Cream is supplied in a 2.5oz tube and retails for $17.99.
Arnicare Arthritis Cream is supplied in a 2.5oz tube and retails for $17.99.
Fast-Act Rheuma Capsule, New Fast-Act Rheumatism Capsule, and UA-Block contain active hidden drug ingredients not listed on the product label.
The device is implanted subcutaneously during an outpatient-compatible procedure.
The approval for Idacio was based on a review of data that showed similar pharmacokinetics, efficacy, safety, and immunogenicity to the reference adalimumab product.
The ongoing phase 3 BE MOBILE 2 study compared the efficacy and safety of bimekizumab to placebo in 332 adults with active ankylosing spondylitis.
The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.
The approval is supported by evidence from adequate and well-controlled studies of Stelara.
The sBLA is supported by data from a phase 1 pharmacokinetics bridging study comparing Hyrimoz 50mg/mL and citrate-free Hyrimoz HCF.
The approval was based on data from the phase 2/3 SELECT-AXIS 1 and the phase 3 SELECT-AXIS 2 trials.
The PAS is supported by data from the REFLECTIONS B538-12 study, which assessed multiple switches between Abrilada and Humira, in addition to methotrexate, in adults with moderate to severe rheumatoid arthritis.